5-HT3 receptor antagonist for the treatment of tendinopathy

Riley G (2008) Tendinopathy—from basic science to treatment. Nat Clin Pract Rheumatol 4: 82–89

Idzko M et al. (2004) The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 172: 6011–6019

Fiebich BL et al. (2004) Expression of 5-HT3A receptors in cells of the immune system. Scand J Rheumatol 33 (Suppl 119): 9–11

Fiebich BL et al. (2004) Antiinflammatory effects of 5-HT3 receptor antagonists in lipopolysaccharide-stimulated primary human monocytes. Scand J Rheumatol 33 (Suppl 119): 28–32

de la Vega L et al. (2005) The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. Biochem Pharmacol 70: 369–380

Muller W et al. (2006) New treatment options using 5-HT3 receptor antagonists in rheumatic diseases. Curr Top Med Chem 6: 2035–2042